Company intelligence / Profile preview

Cetus

Emeryville, California, United Statescetus.zone ↗

Ownership: Private
Development stage: Other

Overview

Cetus was a pioneering biotechnology company that developed several landmark technologies and drugs. Its most notable achievements include the invention of PCR by Kary Mullis and the development of Betaseron for multiple sclerosis and Proleukin for renal cancer. The company faced regulatory setbacks but ultimately saw its products reach market after being acquired[1][3][4].

Therapeutic areas: OncologyNeurology
Modalities: Small moleculeBiologicRecombinant protein
Industry: Biotech

Partnerships

Triton Biosciencescollaborations with academic researchers such as Steven Rosenberg on IL2 trials

Beyond the preview

Go deeper on Cetus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cetus.

Explore the full profile